Back to results
US 8,299,094 B2Granted
Hepatitis C virus inhibitors
AssigneeBristol-Myers Squibb Company
InventorsXiangdong Alan Wang, Li-Qiang Sun, Sing-Yuen Sit, Ny Sin, Paul Michael Scola, Yan Chen
Life of this patent
Estimating the term…
Abstract
Hepatitis C virus inhibitors are disclosed having the general formula: wherein R1, R2, R3, R′, B, Y and X are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
Claims11
A compound of formula (I)
- or a pharmaceutically acceptable salt thereof, wherein:
- R1 is C3-7 cycloalkyl;
- R2 is C2-6 alkenyl;
- R3 is C1-8 alkyl;
- Y is H;
- B is R4O(C═O)—;
- R4 is C1-10 alkyl;
- R′ is a bicyclic heterocycle substituted with two Ra groups;
- and
- each Ra is independently selected from C1-6 alkoxy and halo.
7 more elements
Dependencies are inferred from the claim text.